Stock YCBD CBDMD, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company cbdMD, Inc.

Equities

YCBD

US12482W3097

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 04:10:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
0.9992 USD +8.61% Intraday chart for cbdMD, Inc. -2.04% -3.92%
Apr. 02 CbdMD, Inc. Appoints Brad Whitford as Chief Accounting Officer, Treasurer and Secretary CI
Mar. 29 Transcript : CbdMD, Inc. - Shareholder/Analyst Call

Business Summary

cbdMD, Inc. produces and distributes cannabidiol (CBD) products. The Company owns and operates CBD brands cbdMD, Paw CBD and cbdMD Botanicals. Its cbdMD brand of products includes a range of premium every day and functional CBD products, including tinctures; gummies; topicals; capsules; drink mixes; and sleep, focus and calming aids.Its Paw CBD brand of products includes a line of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths and formulas. Its cbdMD Botanicals brand of beauty and skincare products features facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care stock-keeping units (SKU). cbdMD, Paw CBD and cbdMD Botanicals products are distributed through its e-commerce websites, third party ecommerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers. Its products are sold through www.cbdmd.com, www.pawcbd.com, and cbdmdbotanicals.com Websites.

Number of employees: 52

Sales per Business

USD in Million2022Weight2023Weight Delta
E-Commerce
80.5 %
26 74.7 % 19 80.5 % -26.48%
Wholesale
19.5 %
9 25.3 % 5 19.5 % -47.38%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
35 100.0 % 24 100.0 % -31.77%

Managers

Managers TitleAgeSince
T. Kennedy CEO
 Chief Executive Officer 45 20-09-30
Zeb Booker CTO
 Chief Tech/Sci/R&D Officer - 18-12-31
Sibyl Swift CTO
 Chief Tech/Sci/R&D Officer 43 21-04-28
Shannon Charles SAM
 Sales & Marketing - 22-12-31
Dave Johnson PRN
 Corporate Officer/Principal - 21-11-30
Brad Trawick PRN
 Corporate Officer/Principal - 21-07-21
Francisco Mangual SAM
 Sales & Marketing - 18-10-31
Lance Blundell LAW
 General Counsel 52 17-12-31

Members of the board

Members of the board TitleAgeSince
Bakari Sellers BRD
 Director/Board Member 39 17-02-28
Scott Stephen CHM
 Chairman 58 19-04-18
William Raines BRD
 Director/Board Member 64 19-04-18
Sibyl Swift CTO
 Chief Tech/Sci/R&D Officer 43 21-04-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,045,092 2,399,859 ( 78.81 %) 0 78.81 %
Stock B 0 5,000,000 0 0

Shareholders

NameEquities%Valuation
Raymond Coffman
12.73 %
387,695 12.73 % 360 556 $
Crc Investment Fund LP
4.601 %
140,114 4.601 % 130 306 $
Worldwide Media Services Group, Inc.
4.423 %
134,679 4.423 % 125 251 $
AXS Investments LLC
2.995 %
91,204 2.995 % 84 820 $
Renaissance Technologies LLC
1.028 %
31,311 1.028 % 29 119 $
Sentinus LLC
0.7916 %
24,106 0.7916 % 22 419 $
Virtu Financial LLC
0.7673 %
23,364 0.7673 % 21 729 $
G1 Execution Services LLC
0.5654 %
17,218 0.5654 % 16 013 $
Vanguard Group, Inc. (Subfiler)
0.4283 %
13,042 0.4283 % 12 129 $
Penserra Capital Management LLC
0.4015 %
12,227 0.4015 % 11 371 $
NameEquities%Valuation
Chapin Davis, Inc.
1.600 %
80,000 1.600 % 66 240 $
CSS LLC
1.488 %
74,398 1.488 % 61 602 $
Commonwealth Equity Services LLC
0.2000 %
10,000 0.2000 % 8 280 $
Morgan Stanley Smith Barney LLC
0.0555 %
2,775 0.0555 % 2 298 $
UBS Securities LLC
0.004020 %
201 0.004020 % 166 $

Company contact information

cbdMD, Inc.

8845 Red Oak Boulevard

28217, Charlotte

+

http://www.cbdmd.com
address cbdMD, Inc.(YCBD)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for cbdMD, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.9992 USD
Average target price
2 USD
Spread / Average Target
+100.16%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CBDMD, INC. Stock cbdMD, Inc.
-3.92% 3.04M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+27.97% 672B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+23.36% 550B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.02% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+14.85% 317B
ABBVIE INC. Stock AbbVie Inc.
+6.25% 292B
ASTRAZENECA PLC Stock AstraZeneca PLC
+2.43% 211B
NOVARTIS AG Stock Novartis AG
-0.38% 203B
ROCHE HOLDING AG Stock Roche Holding AG
-9.94% 194B
PFIZER, INC. Stock Pfizer, Inc.
-11.81% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. YCBD Stock
  4. Company cbdMD, Inc.